A study shows that Romanian patients wait, on average, 460 days for access to innovative medicines, seriously affecting critical areas such as oncology.
Andreea Lificiu
Health
https://www.pexels.com/
Always see our news on Google
An analysis carried out by Novartis Romania highlights the long delays in Romanian patients' access to innovative medicines, with an average of 460 days from the approval of compensation by the ANMDM. Oncology is the most affected, with 40% of the indications analyzed. Although the assessment process has improved, the compensation steps remain lengthy. The study emphasizes the need for reforms in the reimbursement system to ensure rapid and equitable access to treatment.
Sources
Studiu: Pacienţii români aşteaptă, în medie, 460 de zile ca să primească medicamentele inovatoare compensate/ Aproximativ 40% din totalul indicaţiilor terapeutice analizate au fost de natură oncologică
Studiu: Pacienţii români aşteaptă, în medie, 460 de zile ca să primească medicamentele inovatoare compensate / Aproximativ 40% din totalul indicaţiilor terapeutice analizate au fost de natură oncologică
Studiu: Pacienţii români aşteaptă, în medie, 460 de zile ca să primească medicamentele inovatoare compensate / Aproximativ 40% din totalul indicaţiilor terapeutice analizate au fost de natură oncologică
Latest News
22:56
Germany will participate with aircraft in the first military exercise of the Coalition of the Willing for Ukraine, which will also partly take place in Romania
22:37
Alexandru Nazare, on the audit requested by Sorin Grindeanu at all ministries: “There is absolutely no problem, it is actually a joy”
22:23
Traian Băsescu claims that Sorin Grindeanu will control the government through Marian Neacșu, while Prime Minister Luca Niculescu could become the target of criticism
22:09
Tens of thousands of Czechs protested in Prague against the reform of public media funding
21:57
Painting by Nicolae Grigorescu, valued at only 3 lei and 50 bani, at the Art Museum in Ploiești
See more news
NEWS ON THE SAME TOPICS
International
Patients in Austria wait up to 65 days for specialist consultations, and many practices are no longer accepting new patients
Current Affairs
FABC, letter to Ilie Bolojan and the head of CNAS: Three oncology medications are missing, and another eight have supply issues.
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
